ATE317266T1 - In vitro methode zur synchronisation von oozytenreifung - Google Patents

In vitro methode zur synchronisation von oozytenreifung

Info

Publication number
ATE317266T1
ATE317266T1 AT00906178T AT00906178T ATE317266T1 AT E317266 T1 ATE317266 T1 AT E317266T1 AT 00906178 T AT00906178 T AT 00906178T AT 00906178 T AT00906178 T AT 00906178T AT E317266 T1 ATE317266 T1 AT E317266T1
Authority
AT
Austria
Prior art keywords
synchronizing
vitro method
oocyte maturation
oocyte
maturation
Prior art date
Application number
AT00906178T
Other languages
English (en)
Inventor
Christian Grondahl
Thomas Host Hansen
Alexander Ruebig
Christa Hegele-Hartung
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE317266T1 publication Critical patent/ATE317266T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00906178T 1999-02-24 2000-02-23 In vitro methode zur synchronisation von oozytenreifung ATE317266T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199900255 1999-02-24
US13081699P 1999-04-23 1999-04-23
DKPA199901310 1999-09-16

Publications (1)

Publication Number Publication Date
ATE317266T1 true ATE317266T1 (de) 2006-02-15

Family

ID=27220546

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906178T ATE317266T1 (de) 1999-02-24 2000-02-23 In vitro methode zur synchronisation von oozytenreifung

Country Status (13)

Country Link
US (1) US6585982B1 (de)
EP (1) EP1156822B1 (de)
JP (1) JP2002537349A (de)
KR (1) KR20010093280A (de)
CN (1) CN1353617A (de)
AT (1) ATE317266T1 (de)
AU (1) AU2794100A (de)
BR (1) BR0008468A (de)
CZ (1) CZ20012967A3 (de)
DE (1) DE60025905T2 (de)
ES (1) ES2258445T3 (de)
HU (1) HUP0200157A3 (de)
WO (1) WO2000050066A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
EP1157096A2 (de) * 1999-02-26 2001-11-28 Novo Nordisk A/S Kulturmedium mit meiosis-aktivierende sterolen (mas) und verfahren zur in vitro fertilisation
US20030153808A1 (en) * 2000-02-25 2003-08-14 Christa Hegele-Hartung Implantation rate using ff-mas
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
WO2001088098A2 (en) * 2000-05-18 2001-11-22 Schering Aktiengesellschaft Fertilization of aged oocytes
EP1287033A2 (de) * 2000-05-25 2003-03-05 Queen's University At Kingston Sperma protein pt32, c-yes aus spermien und cytoplasma von oozyten, sowie verwendung dieser proteine
EP1216701A1 (de) * 2000-12-22 2002-06-26 Schering Aktiengesellschaft Verfahren zur Erhöhung der Konzentration von Meiosis-aktivierenden Sterolen in der Cholesterolsynthese und die Verwendung von potenten Hemmstoffen in das Verfahren
EP1245572A1 (de) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol-Verbindungen, ihre Verwendung zur Herstellung Meiose-regulierender Medikamenten und ein Vefahren zu ihrer Herstellung
AR036592A1 (es) * 2001-09-12 2004-09-22 Applied Research Systems Uso de gch en la hiperestimulacion ovarica controlada
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
EA009279B1 (ru) * 2001-09-12 2007-12-28 Апплайд Резеч Системз Арс Холдинг Н.В. Применение лютеинизирующего гормона человека, в том числе в сочетании с фолликулостимулирующим гормоном, для содействия имплантации и/или снижения частоты выкидышей
WO2003070766A2 (en) * 2002-02-22 2003-08-28 Novo Nordisk A/S A transducer of mas signalling
JP2005518823A (ja) 2002-03-08 2005-06-30 マクギル・ユニバーシテイ 未成熟ヒト卵母細胞の体外成熟
KR20050058285A (ko) * 2002-06-07 2005-06-16 아레스 트레이딩 에스.에이. 조절된 난소 과자극 방법 및 이런 방법에 이용되는제약학적 키트
ES2547953T3 (es) 2004-05-17 2015-10-09 The General Hospital Corporation Composiciones que comprenden células madre germinales femeninas y métodos de uso de las mismas
MY154677A (en) 2006-03-07 2015-07-15 Shroff Geeta Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
AU2012242591B2 (en) 2011-04-14 2014-10-23 The General Hospital Corporation Compositions and methods for autologous germline mitochondrial energy transfer
CA2847292A1 (en) 2011-06-29 2013-01-03 The General Hospital Corporation Compositions and methods for enhancing bioenergetic status in female germ cells
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
HUP9800731A3 (en) * 1995-03-06 2000-03-28 Novo Nordisk As Stimulation of meiosis
AU6122696A (en) * 1995-06-23 1997-01-22 Novo Nordisk A/S Meiosis regulating compounds
KR19990028366A (ko) * 1995-06-23 1999-04-15 켈베르그 라르스 감수분열 조절 화합물
CA2275683A1 (en) * 1996-12-20 1998-07-02 Frederik Christian Gronvald Meiosis regulating compounds
CN1259138A (zh) * 1997-06-04 2000-07-05 阿克佐诺贝尔公司 调节减数分裂的17β－烯丙氧基(硫代)烷基－雄甾烷衍生物
US5866599A (en) * 1997-06-06 1999-02-02 Basf Aktiengesellschaft Fungicidal mixtures
ATE361091T1 (de) * 1999-02-24 2007-05-15 Novo Nordisk As Behandlung von unfruchtbarkeit

Also Published As

Publication number Publication date
WO2000050066A1 (en) 2000-08-31
EP1156822B1 (de) 2006-02-08
US6585982B1 (en) 2003-07-01
DE60025905D1 (de) 2006-04-20
BR0008468A (pt) 2002-02-05
HUP0200157A3 (en) 2002-06-28
JP2002537349A (ja) 2002-11-05
AU2794100A (en) 2000-09-14
KR20010093280A (ko) 2001-10-27
CN1353617A (zh) 2002-06-12
CZ20012967A3 (cs) 2001-12-12
EP1156822A1 (de) 2001-11-28
HUP0200157A2 (hu) 2002-05-29
ES2258445T3 (es) 2006-09-01
DE60025905T2 (de) 2006-09-14

Similar Documents

Publication Publication Date Title
ATE317266T1 (de) In vitro methode zur synchronisation von oozytenreifung
DE50008864D1 (de) Verfahren zur herstellung polyisobutenphenol-haltiger mannichaddukte
DE60026299D1 (de) Vorrichtung zur züchtung von zellkulturen
HK1088597A1 (en) Method for the production of substituted 3-aryl-butyl amine compounds
MXPA05013752A (es) Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos.
SG148217A1 (en) Method for treating adamts-5-associated disease
DK1227726T3 (da) Fremgangsmåde til forbedring af plantevækst
SE0100080L (sv) Nytt förfarande
AU2003276878A8 (en) Process for preparing fluorocarboxylic acids
MXPA03004986A (es) Proceso para preparar polimeros de emulsion con alta pureza.
DE50105968D1 (de) VERFAHREN ZUR HERSTELLUNG VON AlKYLVERBRÜCKTEN LIGANDSYSTEMEN UND ÜBERGANGSMETALLVERBINDUNGEN
DE50015890D1 (de) Verfahren zur synchronisation
ATE294771T1 (de) Mikrobielles verfahren zur herstellung von pravastatin
DE50000523D1 (de) Vorrichtung zur herstellung von einkristallen
DE60233130D1 (de) Verfahren zur herstellung von imipenem
ATE352549T1 (de) Verfahren zur herstellung von desloratadin
NO20015285L (no) Fremstillingsprosess for n¶ringsmiddelfermenterende midler
ATE306942T1 (de) Zusammensetzung zur in-vitro befruchtung
IL152295A0 (en) Method for producing 2-alkyl-3-chlorophenols
DK1341898T3 (da) Fremgangsmåde til aerob fermentering
BR0106265B1 (pt) processo para cultura aeràbica.
EP1447464A4 (de) Kristallherstellungsverfahren für galliumoxid-eisen-mischkristall
EP1646078A4 (de) Epitaxial-wachstumsprozess
ATE309213T1 (de) Verfahren zur herstellung von n-alkenyl-amiden
EP1275729A4 (de) Verfahren zur herstellung einer l-aminosäure durch ein fermentationsverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties